Diabetes Drugs & Gastrointestinal Injuries

Home 9 Current Case 9 Diabetes Drugs & Gastrointestinal Injuries

While initially developed to manage blood sugar levels in diabetes patients, a group of medications has recently gained widespread popularity for weight loss among the general population. These medications, known as GLP-1 receptor agonists, function by stimulating the release of insulin, ultimately suppressing appetite and promoting weight loss. However, their impact on the digestive system can be significant, leading to side effects like vomiting, persistent diarrhea, difficulty consuming food, and stomach paralysis, collectively known as intense gastroparesis.

What Gastrointestinal Injuries Can I Get Compensation For?

Not all gastrointestinal side effects associated with these medications warrant legal action. However, specific injuries, often severe and requiring medical intervention, meet acceptable criteria for seeking compensation. These include:

  • Persistent vomiting: Inability to keep food or liquids down for an extended period, leading to dehydration and electrolyte imbalance.
  • Ileus or bowel obstruction: Temporary or complete blockage of the intestines, causing severe pain, nausea, and bloating, and requiring immediate medical attention.
  • Intestinal blockage: Blockage of the small or large intestine by gallstones, food particles, or other factors, leading to cramping, constipation, and potentially requiring surgical intervention.
  • Gallstone or gallbladder removal: Development of gallstones or the need for gallbladder removal due to complications associated with these medications.

If you or a loved one has experienced any of these gastrointestinal complications after the use of diabetes drugs, our dedicated legal team at Lundy LLP is ready to help.

Concerns for Diabetic Patients

While these drugs benefit diabetic patients by managing blood sugar levels, the risk of gastroparesis is particularly concerning for this population. Diabetic gastroparesis is already a prevalent condition, and the potential interaction with GLP-1 receptor agonists can exacerbate symptoms and significantly impact quality of life.

Concerns for Weight Loss Patients

Although appealing for weight management, these medications are not without risks for patients seeking solely for weight loss. The lack of extensive research on the long-term effects of GLP-1 receptor agonists for non-diabetic individuals raises concerns about potential adverse effects. Additionally, individuals may be unaware of the potential for severe gastrointestinal side effects due to the manufacturer’s insufficient warning labels, leading to delayed diagnosis and treatment.

Mounting Evidence and Insufficient Warnings:

A recent CNN report highlighted the experiences of diabetes drug users prescribed solely for weight loss who developed severe gastrointestinal side effects. This growing body of evidence contradicts the assurances of manufacturers like Novo Nordisk, who maintain the drug’s safety and dismiss concerns about potential risks. Additionally, the lack of clear warnings on the label regarding these risks leaves many users unaware of the potential dangers.

Anticipated Increase in Gastroparesis Cases

As more individuals come forward with accounts of adverse symptoms linked to these drugs, healthcare professionals are anticipating a significant rise in gastroparesis cases. Despite the manufacturers maintaining the drug’s safety and dismissing concerns raised by healthcare professionals, the growing number of reported cases paints a concerning picture.

Our Expertise in Pharmaceutical Injury Cases

Lundy LLP has a proven track record of advocating for individuals who have suffered harm due to pharmaceutical products. We understand the physical, emotional, and financial toll these injuries can take on individuals and their families. With our experienced team of legal professionals, we are committed to holding pharmaceutical companies accountable for the harm caused by their products.

Louisiana Diabetes Drugs Related Injury Attorneys

If you or a loved one has suffered from significant gastrointestinal injuries after using GLP-1 RA medications it’s crucial to seek legal guidance promptly. Contact Lundy LLP to discuss your case with our experienced attorneys.

To initiate the conversation, please reach out to us through the contact form on our website or call us at 337-439-0707. We offer free consultations to evaluate the merits of your case and determine the best course of action for seeking justice.



Over $1 Billion Won For Our Clients

Lundy LLP is one of the leading firms handling catastrophic and serious personal injury cases. Our attorneys have a vast array of experience and success in many fields, including cases and trials involving dangerous drugs, automobile, trucking and boating accidents, pipeline explosions, product liability, dangerous highways, railroads, aviation and wrongful death.

Commercial Litigation


Lundy LLP successfully litigated on behalf of our client securing a $10 Million award in connection with an oil well blowout caused by pressure from the defendant’s salt dome cavern leaking into the adjoining oil and gas fault block.

Catastrophic Brain Injury


Our client received a brain injury as a result of an explosion at a pipeline construction site.

Business Torts & Fraud


Lundy LLP filed a suit on behalf of our client for damages and lost profits resulting from the State of Louisiana’s failure to apply rules and regulations equally to all manufacturers of septic systems.